Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12097176PMC
http://dx.doi.org/10.2215/CJN.0000000710DOI Listing

Publication Analysis

Top Keywords

targeting optimal
4
optimal antibody
4
antibody strategy
4
strategy noninvasive
4
noninvasive diagnosis
4
diagnosis phospholipase
4
phospholipase receptor-associated
4
receptor-associated membranous
4
membranous nephropathy
4
nephropathy serology
4

Similar Publications

Risk factors for coronary in-stent restenosis in Moroccan patients: a retrospective case-control study.

Cell Mol Biol (Noisy-le-grand)

September 2025

Medical School, Laboratory of Genetics and Molecular Pathology, University Hassan II, Casablanca, Morocco.

In-stent restenosis remains a significant challenge in interventional cardiology despite technological advancements. This retrospective case-control study conducted at the University Hospital Center Ibn Rochd in Casablanca (2020-2023) examined risk factors associated with coronary in-stent restenosis in 68 patients equally distributed between restenosis and no-restenosis groups. Diabetes emerged as a powerful predictor of restenosis (RR=4.

View Article and Find Full Text PDF

Discovery of APS03118, a Potent and Selective Next-Generation RET Inhibitor with a Novel Kinase Hinge Scaffold.

J Med Chem

September 2025

Applied Pharmaceutical Science, Inc., Building 10-1, No.2, Jingyuan North Street, BDA, Beijing 100176, China.

This study reports the discovery and preclinical activity of APS03118, a novel selective RET inhibitor featuring a novel tricyclic pyrazolo[3',4':3,4]pyrazolo[1,5-]pyridine hinge-binding scaffold designed to overcome acquired resistance to first-generation selective RET inhibitors (SRIs). By enhancing hydrogen bonding with conserved hinge residues (Glu805, Ala807), APS03118 potently inhibits wild-type RET and diverse resistance mutations, including solvent-front (G810R/S/C), gatekeeper (V804M/L/E), roof (L730I/M), and hinge (Y806C/N/H) variants. In preclinical models, APS03118 induced complete tumor regression in KIF5B-RET and CCDC6-RET V804 M patient-derived xenografts (PDXs) and significantly prolonged survival in an intracranial CCDC6-RET metastasis model.

View Article and Find Full Text PDF

The Discovery of RP-2119: A Potent, Selective, and Orally Bioavailable Polθ ATPase Inhibitor.

J Med Chem

September 2025

Repare Therapeutics, 7171 Frederick-Banting, Building 2, H4S 1Z9 Montréal, Québec, Canada.

DNA polymerase theta (Polθ) plays a critical role in repairing DNA double-strand breaks through microhomology-mediated end joining (MMEJ) and has emerged as a key synthetic lethal drug target in cancers with homologous recombination (HR) deficiencies. Its inhibition has shown a strong potential to synergize with PARP inhibitors, particularly in tumors with deleterious or mutations. Here, we describe the discovery and preclinical development of RP-2119, a selective, potent, and bioavailable Polθ ATPase inhibitor.

View Article and Find Full Text PDF

To explore the alleviating effect of digital supply chain finance (DSCF) on financing constraints experienced by small- and medium-sized enterprises (SMEs), with a view to promoting the digital transformation of enterprises. This observational study utilizes data from Chinese listed enterprises. The study's primary focus is on a selection of SRDI (abbreviation for "specialized, refined, distinctive, and innovative") enterprises in the electronics and machinery industries from 2013 to 2020.

View Article and Find Full Text PDF

Flatness-based control for generalized synchronization of chaotic systems with large dissipation and dimension mismatch.

Chaos

September 2025

Complex Systems Group & Grupo Interdisciplinar de Sistemas Complejos, Universidad Rey Juan Carlos, 28933 Móstoles, Madrid, Spain.

A flat control law is based on the structural analysis of a controlled system, allowing optimal placement of sensors and actuators. Once designed, any desired dynamics can be imposed onto the system. When the target dynamics comes from a system structurally different from the controlled one, generalized synchronization can be achieved, provided the control gain is sufficiently large.

View Article and Find Full Text PDF